Page last updated: 2024-08-21

quinazolines and Skin Diseases, Vascular

quinazolines has been researched along with Skin Diseases, Vascular in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hui, RC; Ko, JH; Shih, YC; Yang, CH	1
Ebi, N; Fukusho, R; Sugimoto, Y; Takahashi, Y; Tsuruno, K; Yamaguchi, O	1

Reviews

1 review(s) available for quinazolines and Skin Diseases, Vascular

Article	Year
[A case of cutaneous vasculitis caused by erlotinib treatment and a review of literature]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2011, Volume: 49, Issue:9 Topics: Aged; Erlotinib Hydrochloride; Female; Humans; Protein Kinase Inhibitors; Quinazolines; Skin Diseases, Vascular; Vasculitis	2011

Other Studies

1 other study(ies) available for quinazolines and Skin Diseases, Vascular

Article	Year
Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7 Topics: Antineoplastic Agents; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lower Extremity; Lung Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Invasiveness; Neoplasm Staging; Prednisolone; Quinazolines; Risk Assessment; Skin Diseases, Vascular; Treatment Outcome; Vasculitis	2011

Article

Year

Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7

Topics: Antineoplastic Agents; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lower Extremity; Lung Neoplasms; Male; Middle Aged; Necrosis; Neoplasm Invasiveness; Neoplasm Staging; Prednisolone; Quinazolines; Risk Assessment; Skin Diseases, Vascular; Treatment Outcome; Vasculitis

2011